[Therapeutic effect of combined use of interferon alpha-1b, interleukin-2 and thalidomide on reversing minimal residual disease in acute myeloid leukemia].
Zhonghua Xue Ye Xue Za Zhi
; 40(2): 111-116, 2019 Feb 14.
Article
en Zh
| MEDLINE
| ID: mdl-30831625
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Leucemia Mieloide Aguda
/
Protocolos de Quimioterapia Combinada Antineoplásica
Tipo de estudio:
Prognostic_studies
Idioma:
Zh
Revista:
Zhonghua Xue Ye Xue Za Zhi
Año:
2019
Tipo del documento:
Article